The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1031
ISSUE1031
July 17, 1998
Rituximab Correction
Med Lett Drugs Ther. 1998 Jul 17;40(1031):74
Disclosures
Objective(s)
SUMMARY: In the Medical Letter article on rituximab (Rituxan - vol 40, page 66, June 19, 1998), the second sentence in the paragraph on Dosage and Cost should say that the rate of infusion can slowly be increased to a maximum of 400 mg/hour.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article